| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9810920.0AGB9810920D0 (en) | 1998-05-21 | 1998-05-21 | Therapeutic use |
| PCT/GB1999/001632WO1999059635A1 (en) | 1998-05-21 | 1999-05-19 | Use of a cox-2 inhibitor and a nk-1 receptor antagonist for treating inflammation |
| EP99922393AEP1079863A1 (en) | 1998-05-21 | 1999-05-19 | Use of a cox-2 inhibitor and a nk-1 receptor antagonist for treating inflammation |
| CA002327585ACA2327585A1 (en) | 1998-05-21 | 1999-05-19 | Use of a cox-2 inhibitor and a nk-1 receptor antagonist for treating inflammation |
| JP2000549299AJP2002515461A (en) | 1998-05-21 | 1999-05-19 | Use of COX-2 inhibitors and NK-1 receptor antagonists for the treatment of inflammation |
| AU39486/99AAU758983B2 (en) | 1998-05-21 | 1999-05-19 | Use of a COX-2 inhibitor and a NK-1 receptor antagonist for treating inflammation |
| US10/614,389US20040097573A1 (en) | 1998-05-21 | 2003-07-07 | Use of a COX-2 inhibitor and a NK-1 receptor antagonist for treating inflammation |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9810920.0AGB9810920D0 (en) | 1998-05-21 | 1998-05-21 | Therapeutic use |
| Publication Number | Publication Date |
|---|---|
| GB9810920D0true GB9810920D0 (en) | 1998-07-22 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB9810920.0ACeasedGB9810920D0 (en) | 1998-05-21 | 1998-05-21 | Therapeutic use |
| Country | Link |
|---|---|
| EP (1) | EP1079863A1 (en) |
| JP (1) | JP2002515461A (en) |
| AU (1) | AU758983B2 (en) |
| CA (1) | CA2327585A1 (en) |
| GB (1) | GB9810920D0 (en) |
| WO (1) | WO1999059635A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7271266B2 (en) | 2002-03-28 | 2007-09-18 | Merck & Co., Inc. | Substituted 2,3-diphenyl pyridines |
| KR20040072004A (en) | 2003-02-07 | 2004-08-16 | 삼성에스디아이 주식회사 | Emitting compound for electroluminescence device and device using thereof |
| PL1745791T3 (en) | 2003-05-07 | 2013-11-29 | Osteologix As | Treating cartilage/bone conditions with water-soluble strontium salts |
| WO2006081088A2 (en)* | 2005-01-24 | 2006-08-03 | Pozen Inc. | Compositions and therapeutic methods utilizing a combination of a protein extravasation inhibitor and an nsaid |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2099233A1 (en)* | 1992-06-29 | 1993-12-30 | Conrad P. Dorn | Morpholine and thiomorpholine tachykinin receptor antagonists |
| GB2287404A (en)* | 1994-03-15 | 1995-09-20 | Pfizer | Antiinflammatory and analgesic compositions |
| KR100517210B1 (en)* | 1994-12-12 | 2006-06-07 | 오메로스 코포레이션 | Infusion solution for pain, inflammation and spasm |
| GB9426103D0 (en)* | 1994-12-23 | 1995-02-22 | Merck Sharp & Dohme | Therapeutic agents |
| JPH11501049A (en)* | 1995-04-04 | 1999-01-26 | グラクソ、グループ、リミテッド | Imidazo [1,2-a] pyridine derivative |
| AU2243897A (en)* | 1996-01-17 | 1997-08-11 | Eli Lilly And Company | Methods of treating or preventing pain or nociception |
| WO1998006708A1 (en)* | 1996-08-14 | 1998-02-19 | G.D. Searle & Co. | Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide |
| US5750549A (en)* | 1996-10-15 | 1998-05-12 | Merck & Co., Inc. | Cycloalkyl tachykinin receptor antagonists |
| Publication number | Publication date |
|---|---|
| JP2002515461A (en) | 2002-05-28 |
| CA2327585A1 (en) | 1999-11-25 |
| AU758983B2 (en) | 2003-04-03 |
| WO1999059635A1 (en) | 1999-11-25 |
| EP1079863A1 (en) | 2001-03-07 |
| AU3948699A (en) | 1999-12-06 |
| Publication | Publication Date | Title |
|---|---|---|
| GB9820113D0 (en) | Therapeutic agents | |
| GB9816263D0 (en) | Therapeutic agents | |
| GB9806102D0 (en) | Therapeutic agents | |
| GB9804885D0 (en) | Therapeutic combination | |
| GB9808663D0 (en) | Therapeutic agents | |
| GB9801234D0 (en) | Therapeutic agents | |
| GB9813576D0 (en) | Therapeutic agents | |
| GB9813006D0 (en) | Therapeutic agents | |
| AP9901436A0 (en) | Therapeutic agents | |
| GB9801210D0 (en) | Therapeutic agents | |
| GB9801397D0 (en) | Therapeutic agents | |
| GB9801202D0 (en) | Therapeutic agents | |
| GB9810092D0 (en) | Therapeutic agents | |
| GB9819484D0 (en) | Therapeutic agents | |
| GB9811879D0 (en) | Therapeutic agents | |
| GB9816897D0 (en) | Therapeutic use | |
| GB9810920D0 (en) | Therapeutic use | |
| GB9812662D0 (en) | Therapeutic use | |
| GB9815317D0 (en) | Therapeutic agents | |
| GB9805716D0 (en) | Therapeutic agents | |
| GB9816723D0 (en) | Therapeutic agents | |
| GB9817838D0 (en) | Therapeutic agents | |
| GB9811624D0 (en) | Therapeutic use | |
| GB9821179D0 (en) | Therapeutic use | |
| GB9812664D0 (en) | Therapeutic use |
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |